Furthermore, NFKBIA upregulation suppresses NF-κB survival signaling and activates SRC-FHIT tumor-suppressive pathways [68,69,70], and CCL15 downregulation diminishes chemotactic and angiogenic activity [71]. The gene discussed is NFKB1; the disease is neoplasm.